Global Lupeol Market Insights, Forecast to 2028

Lupeol is a significant lupane-type triterpene represented in the plant, fungi and animal kingdoms with anticancer, antiprotozoal, chemopreventive and anti-inflammatory properties.So Lupeol is an agent with anti-inflammatory and antioxidant activity.
Market Analysis and Insights: Global Lupeol Market
Due to the COVID-19 pandemic, the global Lupeol market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Min Purity Less Than 98% accounting for % of the Lupeol global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Research segment is altered to an % CAGR throughout this forecast period.
China Lupeol market size is valued at US$ million in 2021, while the US and Europe Lupeol are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Lupeol landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Lupeol include Cayman Chemical, Merck, Santa Cruz Biotechnology, BioVision, Biorbyt, LifeSpan BioSciences, LGC, Biosynth Carbosynth and Selleck Chemicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Lupeol capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Lupeol by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Lupeol Scope and Segment
Lupeol market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Lupeol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Medical
By Company
Cayman Chemical
Merck
Santa Cruz Biotechnology
BioVision
Biorbyt
LifeSpan BioSciences
LGC
Biosynth Carbosynth
Selleck Chemicals
Alfa Chemistry
BOC Sciences
Key Organics
AbMole
Enzo Biochem
Shimadzu
Aladdin
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE